Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells Promotes Delayed Wound Healing in Diabetic Rats
Figure 2
Flow cytometric analysis of BM-MSCs. Most of the cells were positive for markers CD44 and CD90 (72.07% and 89.53%, resp.) and were negative for markers CD34 and CD45 (1.55% and 2.16%, resp.).
